Oncotarget · 2016 · 57 citations · 21 references
PharmacyOncologyPharmaceuticsDrug DeliveryMolecular OncologyNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanomaterials For Drug DeliveryNanomedicineNucleic Acid DeliveryRna InterferenceCancer NanotherapyCellular ProliferationGold Nanoparticle Drug DeliveryMicrorna In CancerMicrorna Regulation In CancerMicrorna TherapeuticsNanoparticlesTumor-targeted Drug Delivery
// Hui-Ying Xue 1, 2, * , Yong Liu 1, 2, * , Jia-Zhi Liao 1 , Ju-Sheng Lin 1 , Bin Li 2 , Wei-Gang Yuan 2 , Robert J. Lee 3 , Lei Li 2 , Chuan-Rui Xu 2 , Xing-Xing He 1 1 Institute of Liver Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2 School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 3 Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA * List of corporate first authors Correspondence to: Xing-Xing He, email: xxhe@tjh.tjmu.edu.cn Chuan-Rui Xu, email: xcr@hust.edu.cn Lei Li, email: leileilesure@163.com Keywords: microRNA, liver cancer, nanomedicine, therapy, AEG-1 Received: September 23, 2016 Accepted: November 02, 2016 Published: November 17, 2016 ABSTRACT MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma (HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a therapy for HCC has not been investigated. In the present study, we have developed a straightforward strategy to deliver miR-375 into HCC cells by assembling miR-375 mimics on the surface of AuNPs and forming AuNP-miR-375 nanoparticles. AuNP-miR-375 exhibits high cellular uptake and preserves miR-375’s activities to suppress cellular proliferation, migration/invasion, and colony formation, and to induce apoptosis in HCC cells. Furthermore, AuNP-delivered miR-375 efficiently downregulated its target genes through RNA interference. In primary and xenograft tumor mouse models, AuNP-miR-375 showed high tumor uptake, therapeutic efficacy, and no apparent toxicity to the host mice. In conclusion, our findings indicate that AuNPs is a reliable strategy to deliver miR-375 into HCC cells and tissue, and that AuNP-miR-375 has the potential in the clinic for treatment of unresectable HCC.
21
Management of Hepatocellular Carcinoma: An Update Δσ
Jordi Bruix, Morris Sherman · Hepatology · 2011 · 8.1K citations · Full text